Segment disclosures

Company overview

콜마바이오텍

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 4 retained observations 2 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3010984725439 KRW20260814Open filing evidence
2026-01-01 – 2026-06-3022014509649 KRW20260814Open filing evidence
2025-04-01 – 2025-06-307087485941 KRW20260814Open filing evidence
2025-01-01 – 2025-06-3015399898128 KRW20260814Open filing evidence